Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis

Keinosuke Ryu, Edwin Choy, Cao Yang, Michiro Susa, Francis J. Hornicek, Henry Mankin, Zhenfeng Duan

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Stat3 expression in cancer may have important prognostic and therapeutic value, but there has been no reports correlating Stat3 expression with prognosis in patients with osteosarcoma. The goal of this study is to correlate patient prognosis with the expression of Stat3 in osteosarcoma tissue and determine the effectiveness of blocking this pathway in osteosarcoma cell lines by Stat3 inhibitor, CDDO-Me. We examine the expression levels of Stat3 and pStat3 in osteosarcoma cell lines and primary tissues by Western blot analysis. We also evaluate the levels of pStat3 expression in osteosarcoma tissue microarray (TMA) by immunohistochemistry. We use clinical data to determine the impact of levels of Stat3 expression on patient prognosis. Finally, we evaluated the effect of CDDO-Me on the inhibition of activated Stat3 pathway in osteosarcoma cell lines using MTT assay and Western blot analysis. Stat3 is observed to be activated in osteosarcoma tissues as well as in cultured cell lines. Overexpression of pStat3 is associated with poor prognosis. CDDO-Me inhibits the growth of osteosarcoma cell lines and induces apoptosis as well. Our results suggest that Stat3 may be a prognostic indicator and potential therapeutic target for osteosarcoma. Blocking the pathway of Stat3 may lead to develop new therapeutic strategies against osteosarcoma.

Original languageEnglish
Pages (from-to)971-978
Number of pages8
JournalJournal of Orthopaedic Research
Volume28
Issue number7
DOIs
Publication statusPublished - 2010 Jul
Externally publishedYes

Fingerprint

STAT3 Transcription Factor
Osteosarcoma
Cell Line
Western Blotting
Cultured Cells
Therapeutics
Immunohistochemistry
Apoptosis

Keywords

  • CDDO-Me
  • Immunohistochemistry
  • Osteosarcoma
  • Prognosis
  • Stat3

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine

Cite this

Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. / Ryu, Keinosuke; Choy, Edwin; Yang, Cao; Susa, Michiro; Hornicek, Francis J.; Mankin, Henry; Duan, Zhenfeng.

In: Journal of Orthopaedic Research, Vol. 28, No. 7, 07.2010, p. 971-978.

Research output: Contribution to journalArticle

Ryu, Keinosuke ; Choy, Edwin ; Yang, Cao ; Susa, Michiro ; Hornicek, Francis J. ; Mankin, Henry ; Duan, Zhenfeng. / Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis. In: Journal of Orthopaedic Research. 2010 ; Vol. 28, No. 7. pp. 971-978.
@article{9f75ccad484d490187fcddd1c6f0a8a2,
title = "Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis",
abstract = "Stat3 expression in cancer may have important prognostic and therapeutic value, but there has been no reports correlating Stat3 expression with prognosis in patients with osteosarcoma. The goal of this study is to correlate patient prognosis with the expression of Stat3 in osteosarcoma tissue and determine the effectiveness of blocking this pathway in osteosarcoma cell lines by Stat3 inhibitor, CDDO-Me. We examine the expression levels of Stat3 and pStat3 in osteosarcoma cell lines and primary tissues by Western blot analysis. We also evaluate the levels of pStat3 expression in osteosarcoma tissue microarray (TMA) by immunohistochemistry. We use clinical data to determine the impact of levels of Stat3 expression on patient prognosis. Finally, we evaluated the effect of CDDO-Me on the inhibition of activated Stat3 pathway in osteosarcoma cell lines using MTT assay and Western blot analysis. Stat3 is observed to be activated in osteosarcoma tissues as well as in cultured cell lines. Overexpression of pStat3 is associated with poor prognosis. CDDO-Me inhibits the growth of osteosarcoma cell lines and induces apoptosis as well. Our results suggest that Stat3 may be a prognostic indicator and potential therapeutic target for osteosarcoma. Blocking the pathway of Stat3 may lead to develop new therapeutic strategies against osteosarcoma.",
keywords = "CDDO-Me, Immunohistochemistry, Osteosarcoma, Prognosis, Stat3",
author = "Keinosuke Ryu and Edwin Choy and Cao Yang and Michiro Susa and Hornicek, {Francis J.} and Henry Mankin and Zhenfeng Duan",
year = "2010",
month = "7",
doi = "10.1002/jor.21088",
language = "English",
volume = "28",
pages = "971--978",
journal = "Journal of Orthopaedic Research",
issn = "0736-0266",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis

AU - Ryu, Keinosuke

AU - Choy, Edwin

AU - Yang, Cao

AU - Susa, Michiro

AU - Hornicek, Francis J.

AU - Mankin, Henry

AU - Duan, Zhenfeng

PY - 2010/7

Y1 - 2010/7

N2 - Stat3 expression in cancer may have important prognostic and therapeutic value, but there has been no reports correlating Stat3 expression with prognosis in patients with osteosarcoma. The goal of this study is to correlate patient prognosis with the expression of Stat3 in osteosarcoma tissue and determine the effectiveness of blocking this pathway in osteosarcoma cell lines by Stat3 inhibitor, CDDO-Me. We examine the expression levels of Stat3 and pStat3 in osteosarcoma cell lines and primary tissues by Western blot analysis. We also evaluate the levels of pStat3 expression in osteosarcoma tissue microarray (TMA) by immunohistochemistry. We use clinical data to determine the impact of levels of Stat3 expression on patient prognosis. Finally, we evaluated the effect of CDDO-Me on the inhibition of activated Stat3 pathway in osteosarcoma cell lines using MTT assay and Western blot analysis. Stat3 is observed to be activated in osteosarcoma tissues as well as in cultured cell lines. Overexpression of pStat3 is associated with poor prognosis. CDDO-Me inhibits the growth of osteosarcoma cell lines and induces apoptosis as well. Our results suggest that Stat3 may be a prognostic indicator and potential therapeutic target for osteosarcoma. Blocking the pathway of Stat3 may lead to develop new therapeutic strategies against osteosarcoma.

AB - Stat3 expression in cancer may have important prognostic and therapeutic value, but there has been no reports correlating Stat3 expression with prognosis in patients with osteosarcoma. The goal of this study is to correlate patient prognosis with the expression of Stat3 in osteosarcoma tissue and determine the effectiveness of blocking this pathway in osteosarcoma cell lines by Stat3 inhibitor, CDDO-Me. We examine the expression levels of Stat3 and pStat3 in osteosarcoma cell lines and primary tissues by Western blot analysis. We also evaluate the levels of pStat3 expression in osteosarcoma tissue microarray (TMA) by immunohistochemistry. We use clinical data to determine the impact of levels of Stat3 expression on patient prognosis. Finally, we evaluated the effect of CDDO-Me on the inhibition of activated Stat3 pathway in osteosarcoma cell lines using MTT assay and Western blot analysis. Stat3 is observed to be activated in osteosarcoma tissues as well as in cultured cell lines. Overexpression of pStat3 is associated with poor prognosis. CDDO-Me inhibits the growth of osteosarcoma cell lines and induces apoptosis as well. Our results suggest that Stat3 may be a prognostic indicator and potential therapeutic target for osteosarcoma. Blocking the pathway of Stat3 may lead to develop new therapeutic strategies against osteosarcoma.

KW - CDDO-Me

KW - Immunohistochemistry

KW - Osteosarcoma

KW - Prognosis

KW - Stat3

UR - http://www.scopus.com/inward/record.url?scp=77953193002&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953193002&partnerID=8YFLogxK

U2 - 10.1002/jor.21088

DO - 10.1002/jor.21088

M3 - Article

C2 - 20063378

AN - SCOPUS:77953193002

VL - 28

SP - 971

EP - 978

JO - Journal of Orthopaedic Research

JF - Journal of Orthopaedic Research

SN - 0736-0266

IS - 7

ER -